Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Enteropathy-Associated T-Cell Lymphoma × duvelisib × 1 year × Clear all

Sponsor

Conditions

Lymphoma, T-Cell 4 Recurrence 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia, Prolymphocytic, T-Cell 2 Squamous Cell Carcinoma of Head and Neck 1 Sezary Syndrome 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Plasma Cell 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Lymphoid 1 Leukemia, Large Granular Lymphocytic 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 3 etoposide phosphate 2 Prednisone 2 Etoposide 2 Doxorubicin 2 Brentuximab Vedotin 2 tazemetostat 1 prednylidene 1 pembrolizumab 1 fludarabine 1 deltacortene 1 Vincristine 1 Prednisolone 1 Melphalan 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡